Spinal P2X 7 receptor mediates microglia activation-induced neuropathic pain in the sciatic nerve injury rat model

Behavioural Brain Research

Volumn 226, Issue 1, 2012, Pages 163-170

  He, Wen Juan ^a   Cui, Jian ^a   Du, Lu ^a   Zhao, Yan Dong ^a   Burnstock, Geoffrey ^b   Zhou, Hua Dong ^c   Ruan, Huai Zhen ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Brilliant Blue G(BBG); Chronic constriction of the sciatic nerve(CCI); Microglia; Neuropathic pain; P2X 7 receptor

Indexed keywords

BRILLIANT BLUE; CHLOROFORM; PURINERGIC P2X7 RECEPTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; HEAT SENSITIVITY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MICROGLIA; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SPINAL CORD DORSAL HORN; SPINAL CORD INJURY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; HYPERALGESIA; MICROGLIA; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; PERIPHERAL NERVE INJURIES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X7; SCIATIC NERVE; SPINAL CORD;

EID: 80053341816     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.09.015     Document Type: Article

References (47)

1. Clark J.D. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manag 2002, 23:131-137.
2. Scholz J., Woolf C.J. Can we conquer pain?. Nat Neurosci 2002, 5 Suppl:1062-1067.
3. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001, 429:23-37.
4. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 2007, 87:659-797.
5. Tsuda M., Tozaki-Saitoh H., Inoue K. Pain and purinergic signaling. Brain Res Rev 2010, 63:222-232.
6. Xiao Z., Ou S., He W.J., Zhao Y.D., Liu X.H., Ruan H.Z. Role of midbrain periaqueductal gray P2X3 receptors in electroacupuncture-mediated endogenous pain modulatory systems. Brain Res 2010, 1330:31-44.
7. Burnstock G. Purine and pyrimidine receptors. Cell Mol Life Sci 2007, 64:1471-1483.
8. Burnstock G., Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 2004, 240:31-304.
9. Ruan H.Z., Birder L.A., de Groat W.C., Tai C., Roppolo J., Buffington C.A., et al. Localization of P2X and P2Y receptors in dorsal root ganglia of the cat. J Histochem Cytochem 2005, 53:1273-1282.
10. Zeng J.W., Liu X.H., Zhao Y.D., Xiao Z., He W.J., Hu Z.A., et al. Role of P2Y1 receptor in astroglia-to-neuron signaling at dorsal spinal cord. J Neurosci Res 2009, 87:2667-2676.
11. North R.A. Molecular physiology of P2X receptors. Physiol Rev 2002, 82:1013-1067.
12. Monif M., Reid C.A., Powell K.L., Smart M.L., Williams D.A. The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J Neurosci 2009, 29:3781-3791.
13. Chessell I.P., Hatcher J.P., Bountra C., Michel A.D., Hughes J.P., Green P., et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005, 114:386-396.
14. Honore P., Donnelly-Roberts D., Namovic M.T., Hsieh G., Zhu C.Z., Mikusa J.P., et al. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 2006, 319:1376-1385.
15. McGaraughty S., Chu K.L., Namovic M.T., Donnelly-Roberts D.L., Harris R.R., Zhang X.F., et al. P2X7-related modulation of pathological nociception in rats. Neuroscience 2007, 146:1817-1828.
16. Broom D.C., Matson D.J., Bradshaw E., Buck M.E., Meade R., Coombs S., et al. Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation. J Pharmacol Exp Ther 2008, 327:620-633.
17. Chu Y.X., Zhang Y., Zhang Y.Q., Zhao Z.Q. Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses. Brain Behav Immun 2010, 24:1176-1189.
18. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.
19. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
20. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63.
21. Li X.S., Zhang Y. Study on dissociation behaviors of methane hydrate in porous media based on experiments and fractional dimension shrinking-core model. Ind Eng Chem Res 2011, 50:8263-8271.
22. Inoue K., Tsuda M. Microglia and neuropathic pain. Glia 2009, 57:1469-1479.
23. Burnstock G. Purinergic receptors and pain. Curr Pharm Des 2009, 15:1717-1735.
24. Zhang X.F., Han P., Faltynek C.R., Jarvis M.F., Shieh C.C. Functional expression of P2X7 receptors in non-neuronal cells of rat dorsal root ganglia. Brain Res 2005, 1052:63-70.
25. Remy M., Thaler S., Schumann R.G., May C.A., Fiedorowicz M., Schuettauf F., et al. An in vivo evaluation of Brilliant Blue G in animals and humans. Br J Ophthalmol 2008, 92:1142-1147.
26. Jiang L.H., Mackenzie A.B., North R.A., Surprenant A. Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol Pharmacol 2000, 58:82-88.
27. Duan S., Anderson C.M., Keung E.C., Chen Y., Swanson R.A. P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J Neurosci 2003, 23:1320-1328.
28. Franke H., Gunther A., Grosche J., Schmidt R., Rossner S., Reinhardt R., et al. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol 2004, 63:686-699.
29. Wang X., Arcuino G., Takano T., Lin J., Peng W.G., Wan P., et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 2004, 10:821-827.
30. James G., Butt A.M., P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system Eur J Pharmacol 2002, 447:247-260.
31. Deuchars S.A., Atkinson L., Brooke R.E., Musa H., Milligan C.J., Batten T.F., et al. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 2001, 21:7143-7152.
32. Deng Z., Fyffe R.E. Expression of P2X7 receptor immunoreactivity in distinct subsets of synaptic terminals in the ventral horn of rat lumbar spinal cord. Brain Res 2004, 1020:53-61.
33. Sim J.A., Young M.T., Sung H.Y., North R.A., Surprenant A. Reanalysis of P2X7 receptor expression in rodent brain. J Neurosci 2004, 24:6307-6314.
34. Cotrina M.L., Nedergaard M. Physiological and pathological functions of P2X7 receptor in the spinal cord. Purinergic Signal 2009, 5:223-232.
35. Rappold P.M., Lynd-Balta E., Joseph S.A. P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain. Brain Res 2006, 1089:171-178.
36. Zhou D., Chen M.L., Zhang Y.Q., Zhao Z.Q. Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats. J Neurosci 2010, 30:8042-8047.
37. Yu Y., Ugawa S., Ueda T., Ishida Y., Inoue K., Kyaw N.A., et al. Cellular localization of P2X7 receptor mRNA in the rat brain. Brain Res 2008, 1194:45-55.
38. Coyle D.E. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 1998, 23:75-83.
39. Tanga F.Y., Raghavendra V., DeLeo J.A. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 2004, 45:397-407.
40. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005, 8:752-758.
41. Di Virgilio F. Purinergic signalling between axons and microglia. Novartis Found Symp 2006, 276:253-258. discussion 9-62, 75-81.
42. Parvathenani L.K., Tertyshnikova S., Greco C.R., Roberts S.B., Robertson B., Posmantur R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 2003, 278:13309-13317.
43. McLarnon J.G., Ryu J.K., Walker D.G., Choi H.B. Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus. J Neuropathol Exp Neurol 2006, 65:1090-1097.
44. Yiangou Y., Facer P., Durrenberger P., Chessell I.P., Naylor A., Bountra C., et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 2006, 6:12.
45. Yanagisawa D., Kitamura Y., Takata K., Hide I., Nakata Y., Taniguchi T. Possible involvement of P2X7 receptor activation in microglial neuroprotection against focal cerebral ischemia in rats. Biol Pharm Bull 2008, 31:1121-1130.
46. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev 1995, 20:269-287.
47. Echeverry S., Shi X.Q., Zhang J. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain 2008, 135:37-47.